Jubilant Ingrevia Limited — Updates, 22-07-2026: Press Release
22-07-2026 | 02:33 pm
22-07-2026 | 02:33 pm
Jubilant Ingrevia reported robust Q1'FY27: Revenue +25% YoY to 1,300 Cr, EBITDA +37% to 209 Cr, PAT +41% to 106 Cr. Growth was driven by Specialty Chemicals, Nutrition, and a strong rebound in Chemical Intermediates. A new Multi-Purpose Plant and CDMO pipeline offer future growth.
No comments yet. Be the first to comment!
